13,773 results on '"Her2"'
Search Results
2. The UK National External Quality Assessment Scheme for Immunocytochemistry and In-Situ Hybridisation (UK NEQAS ICC & ISH) HER2-low EQA programme: a review of results and factors influencing successful staining
3. Antibody-drug conjugates in NSCLC with actionable genomic alterations: Optimizing smart delivery of chemotherapy to the target
4. LRP1 involvement in FHIT-regulated HER2 signaling in non-small cell lung cancer
5. Disitamab vedotin plus toripalimab in patients with locally advanced or metastatic urothelial carcinoma (RC48-C014): a phase Ib/II dose-escalation and dose-expansion study
6. TIM3 on natural killer cells regulates antibody-dependent cellular cytotoxicity in HER2-positive gastric cancer
7. Dynamic characterization of circulating tumor DNA in HER2-altered advanced non-small cell lung cancer treated with pyrotinib and apatinib: Exploratory biomarker analysis from PATHER2 study
8. Trastuzumab deruxtecan in human epidermal growth factor receptor 2-positive breast cancer brain metastases: A systematic review and updated meta-analysis
9. Optimizing combination targeted immunotoxin therapy: Insights from HER2 and EpCAM expression profiles
10. The effect of prolonged cold ischemia time on breast cancer biomarker expression after neoadjuvant chemotherapy
11. Trends in breast cancer among elderly women: Development in estrogen and HER2 subtypes in the last ten years
12. Improving the performance of multi-stage HER2 breast cancer detection in hematoxylin-eosin images based on ensemble deep learning
13. Evidence for Unified Assessment Criteria of HER2 Immunohistochemistry in Colorectal Carcinoma
14. Silver Jubilee of HER2 targeting: a clinical success in breast cancer
15. Monitoring Immunohistochemical Staining Variations Using Artificial Intelligence on Standardized Controls
16. Non-invasive Assessment of Human Epidermal Growth Factor Receptor 2 Expression in Gastric Cancer Based on Deep Learning: A Computed Tomography-based Multicenter Study
17. An immunohistochemical and molecular genetic study of 60 colorectal carcinoma brain metastases in pursuit of predictive biomarkers for cancer therapy
18. Development of two machine learning models to predict conversion from primary HER2-0 breast cancer to HER2-low metastases: a proof-of-concept study
19. AYVM to AYMM Transition on HER2 Exon 20 Insertion Induces Tyrosine Kinase Inhibitor Resistance in NSCLC
20. Sponge-like Au@Ru nanozyme-labeled electrochemical immunosensor platform on the trimetallic Au@Pt@Ag NPs decorated surface for the sensitive detection of HER2
21. Evidence for cytoprotective autophagy in response to HER2-targeted monoclonal antibodies
22. Brain Metastases from Esophageal Cancer: A Retrospective Review from a Single Institution
23. PhyIndBC: Development of a machine learning tool for screening of potential breast cancer inhibitors from phytochemicals
24. Claudin 18.2 Expression in 1404 Digestive Tract Adenocarcinomas Including 1175 Colorectal Carcinomas: Distinct Colorectal Carcinoma Subtypes Are Claudin 18.2 Positive
25. Updated efficacy and safety of HLX02 versus reference trastuzumab in metastatic HER2-positive breast cancer: A randomized phase III equivalence trial
26. Independent Validation of a HER2-Low Focused Immunohistochemistry Scoring System for Enhanced Pathologist Precision and Consistency
27. Production and functional analysis of a phage displayed scFv recombinant antibody targeting EGFR/HER2 dimerization domain
28. Cell division cycle 6 is an independent prognostic biomarker in breast cancer
29. Review: Merging from traditional to potential novel breast cancer biomarkers
30. MRI-based vector radiomics for predicting breast cancer HER2 status and its changes after neoadjuvant therapy
31. Influence of PEGylation on HER2-targeting retro A9 peptide analogue
32. Na+/H+-exchange inhibition by cariporide is compensated via Na+,HCO3−-cotransport and has no net growth consequences for ErbB2-driven breast carcinomas
33. Overexpression of mir-489–3p inhibits proliferation and migration of non-small cell lung cancer cells by suppressing the HER2/PI3K/AKT/Snail signaling pathway
34. Artificial intelligence for assisted HER2 immunohistochemistry evaluation of breast cancer: A systematic review and meta-analysis
35. Alteration of HER2 Status During Breast Cancer Progression: A Clinicopathological Analysis Focusing on HER2-Low Status
36. Albumin incorporation into recognising layer of HER2-specific magnetic nanoparticles as a tool for optimal targeting of the acidic tumor microenvironment
37. Augmented antitumor immune responses of HER2-targeted pyroptotic induction by long-lasting recombinant immunopyroptotins
38. The relationship between HER2 status acquired from pathological data and metabolic parameters from pre-treatment [18F]FDG PET/CT in gastric adenocarcinomas
39. Development and validation of Ran as a prognostic marker in stage I and stage II primary breast cancer
40. Emerging insights into mechanisms of trastuzumab resistance in HER2-positive cancers
41. Molecular characteristics of gastric cancer with ERBB2 amplification
42. Crotamine-based recombinant immunotoxin targeting HER2 for enhanced cancer cell specificity and cytotoxicity
43. Lyophilized liposomal formulation of a peptidomimetic-Dox conjugate for HER2 positive breast and lung cancer
44. Characterizing treatment resistance in muscle invasive bladder cancer using the chicken egg chorioallantoic membrane patient-derived xenograft model
45. ABL kinases regulate translation in HER2+ cells through Y-box-binding protein 1 to facilitate colonization of the brain
46. The Nrf2 inhibitor brusatol synergistically enhances the cytotoxic effect of lapatinib in HER2-positive cancers
47. HER2-Positive Breast Cancer Treatment and Resistance
48. Leveraging IHC Staining to Prompt HER2 Status Prediction from HE-Stained Histopathology Whole Slide Images
49. HER2 overexpression in urothelial carcinoma with GATA3 and PPARG copy number gains.
50. Loss of ERα involved-HER2 induction mediated by the FOXO3a signaling pathway in fulvestrant-resistant breast cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.